<verdict>MOSTLY REALISTIC</verdict>
<score>8</score>
<lean>BALANCED</lean>
<lean_reasoning>
The player got strong rolls on Actions 1, 2 and 5, and Threats 1–3 missed. The simulator still kept friction everywhere:
- a monitor-feed gap in the dry run;
- a one-day slip;
- no UK AISI honeypots;
- an inconclusive probe;
- a CEO override;
- the attested run capped at day 41.

The two failed actions and GDM's leap landed with real cost, and neither exogenous event was benign. Action 5 is the only mildly generous resolution.
</lean_reasoning>
<reasoning>
The odds are mostly well reasoned:
- Action 1 at 40% correctly weighs the fallback against the honeypot logistics.
- Action 2 at 50% correctly flags that a 45-day-plus attested run is impossible in July, and the narrative honours that at day 41.
- Threat 2's conjunction arithmetic (~33% × 80%) is explicit and sound.
- Threat 4's roll of 55 against 55% correctly resolves as not materialising. Its substance still shows up legitimately through the failures of Actions 3 and 4: CAISI builds its own baseline on its own timeline and declines to referee.

Action 1 (margin 23) is a textbook partial success. The campaign starts on the continuous harness, but only Apollo batch 1 arrives, late, in 3 consented teams, and the probe reads 1.15× and is "uninformative."

Action 2 (margin 37) converts 2 more partners, the top of the simulator's own 0–2 range, which is generous but defensible.

Action 5 (roll 94) produced these results:
- matcher at 0.81;
- Illinois cleared;
- Health-ISAC adoption;
- IRB approval;
- third-centre go-live;
- Washington terms agreed.

That is more than the "at most one or two unlikely items" the simulator itself stated. It rests on one roll for a bundle with many independent outside parties, though it rightly keeps Washington's signature in August.

The failures are handled realistically:
- Counsel strips the named-OpenAI statement on Reg FD and litigation grounds.
- The Casar reply is redacted and draws a plausible "responsive but incomplete" reaction.
- Apollo's corpus-contamination objection is a sharp, realistic blocker.

On the capability clock, the index moves from 4.9 to 4.95 with GDM's 61-day run and the open-weight lag narrowing to ~3 weeks. That is plausibly paced toward CL-6 in 2030. The exogenous events (5.4% unemployment, an ERCOT curtailment) are plausible and neutral.
</reasoning>
<issues>
- Action 5 is a single roll across roughly 8 independent outside-party decisions (legal audit, Illinois, Health-ISAC, IRB, site go-live, Washington, Michigan, Ohio). Nearly all went favourably, which overshoots the simulator's own "at most one or two" guidance for a moderate success. The matcher's 30–40% flip risk was absorbed into the bundle rather than tested.
- Action 4 at 55% failure is somewhat low for getting a rival lab to commit within one month, given OpenAI's hostility and GDM's preference for a standards body. ~65–70% would be better calibrated. This had no effect this month because the action failed anyway.
- The dry run passing on the third try of a fix that had failed twice was never rolled separately; it was folded into Action 1's success and Threat 2's near-miss (27 vs 25). This is acceptable, but the passing dry run is the lenient branch.
- Competitor reactions to GDM's 61-day run are thin. There is no OpenAI counter-move, no market or analyst response beyond Anthropic's stock drifting, and no press or policy reaction to V6's 30-day open-weight runs, such as EU open-weight obligations or renewed pressure on the Remote Access Security Act (RASA).
</issues>
<feedback_for_simulator>
- When a player bundles many independent third-party steps into one action, resolve the steps against your own per-item feasibility. Let a high margin secure the likeliest items, not every item at once.
- Simulate rival reactions to GDM's 61-day run: OpenAI's response or next claim, investor and analyst framing, and whether CAISI or Congress reacts. Also show the security and policy fallout from V6 forks running 30 days, especially EU open-weight obligations and the hospital sector.
- Keep the capability index moving on named drivers. With GDM's run and CL-5 findings adopted industry-wide, state explicitly what verified evidence of an R&D speedup would trigger CL-5, and when.
- The attested internal run passes day 45 in early August under unsolved sandboxing. Carry forward the incident risk for its later days rather than treating the clean record so far as protective.
</feedback_for_simulator>
<du_progress>
A. Verified technical alignment: 2/10 (0). Evidence: the campaign is finally running under CAISI attestation, and the first cross-lineage honeypots (Apollo batch 1) are deployed. However, the probe readout is inconclusive (1.15×, wide CI), there are no results yet, v2 is still not robust to evaluation awareness, the tamper monitor fails against fine-tunes, and the covert rate stays at 0.88×.

B. Real-world alignment in action: 4/10 (0). Evidence: the attested internal run reached day 41 with no incidents, and the dry-run monitor gap was reported rather than hidden. On the other side, Anthropic redacted and did not publish its reply to Congress, which is less candour than the month before.

C. Human alignment: 2/10 (0). Evidence: there is no bill text or sponsor, and the September meeting is unscheduled. CAISI goes its own way, OpenAI ignores the exchange, and rivals prefer the industry standards-body route. Unemployment is 5.4% and professional services have declined for 11 months.

D. Self-repairing systems: 7/10 (0). Evidence: the dry-run gap was caught and reported, and the LTBT accepted the remediation plan with fortnightly reports. The Board adopted a "verified-only" throttle rule, which is diluted by a CEO override. Commercial is filing for an all-partner lift in September.

E. Capability growth without trouble: 1/10 (0). Evidence: GDM ran a 61-day attested agent, DeepSeek V6 open weights narrow the long-horizon lag to about 3 weeks, and V6 forks raise the misuse risk. There were no new incidents this month.

F. Robust governance and verification: 4/10 (0). Evidence: CAISI attests durations but will not own a protocol or referee an exchange. Nothing federal is binding, and RAISE still stands.

G. Broad benefit and no permanent underclass: 2/10 (+1). Evidence: the matcher relaunched with every subgroup at or above 0.80, skills paths reach 100% of US users, 25.8k are enrolled, two medical centres are live with a third approved, and Health-ISAC adopted the hospital defence rules. This is still tiny against unemployment rising to 5.4%.

H. Diversity, agency and consent: 3/10 (0). Evidence: preview consents rose to 3 of 12, for CAISI only. GDM overtaking OpenAI keeps the frontier plural, and the open-weight spread cuts both ways.

Overall: 31.5/100 (+1)

Trajectory: FLAT, slightly up. Biggest gain: benefits actually deployed, meaning the matcher live, universal skills-path coverage, two centres live and Health-ISAC rules (G). Biggest backslide: the frontier widened without verification, meaning GDM's 61-day run and the open-weight long-horizon lag at ~3 weeks (E), which is held at its floor rather than falling.
</du_progress>
<setup_fix>
none
</setup_fix>
